{"id":"W2157717971","doi":"10.1093/annonc/mdp328","title":"N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Docetaxel; Irinotecan; Metastatic breast cancer; Internal medicine; Regimen; Taxane; Neutropenia; Breast cancer; Oncology; Febrile neutropenia; Cancer; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Surgery; Phases of clinical research; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405215,0.001372689,0.001957892,0.0003659101,0.0004856449,0.0008474306,0.0008961167,0.001075875,0.01016791],"category_scores_gemma":[0.0009800354,0.00051962,0.001275406,0.0004322995,0.0009731946,0.0008787522,0.0004316334,0.003127987,0.00211297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001520613,"about_ca_system_score_gemma":0.002236167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003873711,"about_ca_topic_score_gemma":0.01967785,"domain_scores_codex":[0.9996458,0.0001829861,0.000009668595,0.00006017075,0.00003276648,0.00006860623],"domain_scores_gemma":[0.9994513,0.0000674589,0.00008187913,0.0000455879,0.00002852878,0.0003252846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7822222,0.02148905,0.003801195,0.000910515,0.001446516,0.0002640522,0.0002908638,0.002731785,0.01403936,0.0008558233,0.03029895,0.1416497],"study_design_scores_gemma":[0.8802814,0.1007932,0.00902769,0.00006361815,0.0003960618,0.0003101709,0.00006782096,0.001251649,0.0007436946,0.0005433153,0.006488148,0.00003313501],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977785,0.00432103,0.0004839895,0.002837473,0.000529587,0.002027,0.002362591,0.0002660093,0.009387504],"genre_scores_gemma":[0.9587291,0.003675623,0.002634272,0.003429638,0.0003557371,0.002769173,0.004562585,0.0001299537,0.02371388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01016791,"threshold_uncertainty_score":0.034015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09833561280837098,"score_gpt":0.4493229086131375,"score_spread":0.3509872958047665,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}